Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection

Abstract

Objective: This study aimed to assess the presence of novel coronavirus in tears and conjunctival secretions of SARS-CoV-2-infected patients.Methods: A prospective interventional case series study was performed, and 30 confirmed novel coronavirus pneumonia (NCP) patients were selected at the First Affiliated Hospital of Zhejiang University from 26 January 2020 to 9 February 2020. At an interval of 2 to 3 days, tear and conjunctival secretions were collected twice with disposable sampling swabs for reverse-transcription polymerase chain reaction (RT-PCR) assay.Results: Twenty-one common-type and nine severe-type NCP patients were enrolled. Two samples of tear and conjunctival secretions were obtained from the only one patient with conjunctivitis yielded positive RT-PCR results. Fifty-eight samples from other patents were all negative. Conclusion:We speculate that SARS-CoV-2 may be detected in the tears and conjunctival secretions in NCP patients with conjunctivitis.

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

“…Consistently, SARS-CoV-2 RNA was also dectected in gastrointestinal tissues from COVID-19 patients [24]. Moreover, SARS-CoV-2 was detected in the tears and conjunctival secretions of covid-19 patients [25]. Meanwhile, a retrospective study based nine pregnant women with COVID-19 had for the first time indicated that the possibility of intrauterine vertical transmission between mothers and infants in the late pregnancy was temporarily excluded [26].…”

Coronavirus disease 2019 (COVID-19): current status and future perspectives

“…Close contact is also a source of transmission of SARS-CoV-2. For example, SARS-CoV-2 can be transmitted through direct or indirect contact with mucous membranes in the eyes, mouth or nose [37][38][39] . There is also a possibility of aerosol transmission in a relatively closed environment with continuous exposure to high concentrations of aerosol.…”

Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context

“…intérêt de la télémédecine dans un contexte de pandémie Alejandra Daruich, 1,2 Daniel Martin, 3 Dominique Bremond-Gignac 1,2 *…”